All News #Library
Rare Diseases
Mereo Biopharma Reveals Setrusumab (UX143) Phase 3 Results
29 Dec 2025 //
GLOBENEWSWIRE
Ultragenyx, Mereo Plummet After Rare Diseases Trial Result
11 Jul 2025 //
GLOBENEWSWIRE
Mereo BioPharma To Participate In Cantor Global Healthcare Conference
12 Sep 2024 //
GLOBENEWSWIRE
Mereo BioPharma Receives FDA Rare Pediatric Disease Designation for Setrusumab
25 Sep 2020 //
GLOBENEWSWIRE

Market Place
Sourcing Support